chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Contusion, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: arm still hurts; shortness of breath; her right arm hurt a lot at the injection site; Numbness on right side of nose, mouth, chin, and jaw; This is a spontaneous report from a contactable consumer (patient herself). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Expiration date: Not reported), via an unspecified route of administration, administered in arm right on 12Feb2021 (Batch/Lot Number: EL9262) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported that she reported online that the shot did not hurt, states soon after, her right arm hurt a lot at the injection site, on 12Feb2021 evening around 19:00 the right side of her nose went numb, states then the right side of her mouth went numb, states the numbness continued down into chin and jaw on 13Feb2021 (Saturday) and 14Feb2021 (Sunday). Sometimes she feels like she was having shortness of breath, (13Feb2021) started 24 hours later. Reported everything but the shortness of breath online. On an unknown date, the patient reported that her arm is still very achy at site of injection and she doesn't feel like herself. . States the numbness has dissipated. The outcome of the events her right arm hurt a lot at the injection site, arm still hurts was unknown, shortness of breath was not resolved, numbness on right side of nose, mouth, chin, and jaw outcome resolved on an unknown date Feb2021.  Follow-up attempts completed. No further information expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Hypoaesthesia, Pain in extremity, Vaccination site pain
Clinical narrative: arm still hurts; shortness of breath; her right arm hurt a lot at the injection site; Numbness on right side of nose, mouth, chin, and jaw; This is a spontaneous report from a contactable consumer (patient herself). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Expiration date: Not reported), via an unspecified route of administration, administered in arm right on 12Feb2021 (Batch/Lot Number: EL9262) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported that she reported online that the shot did not hurt, states soon after, her right arm hurt a lot at the injection site, on 12Feb2021 evening around 19:00 the right side of her nose went numb, states then the right side of her mouth went numb, states the numbness continued down into chin and jaw on 13Feb2021 (Saturday) and 14Feb2021 (Sunday). Sometimes she feels like she was having shortness of breath, (13Feb2021) started 24 hours later. Reported everything but the shortness of breath online. On an unknown date, the patient reported that her arm is still very achy at site of injection and she doesn't feel like herself. . States the numbness has dissipated. The outcome of the events her right arm hurt a lot at the injection site, arm still hurts was unknown, shortness of breath was not resolved, numbness on right side of nose, mouth, chin, and jaw outcome resolved on an unknown date Feb2021.  Follow-up attempts completed. No further information expected.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Dizziness, Loss of consciousness, Resuscitation, Seizure like phenomena
Clinical narrative: Death from a cardiac event. Vaccination received 03/02/2021 in the morning before work. Cardiac emergency and EMS called to home at 11 pm 03/02/2021. Pt passed away 2 hours later at approximately 1 am 03/03/2021.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unresponsive to stimuli
Clinical narrative: Death from a cardiac event. Vaccination received 03/02/2021 in the morning before work. Cardiac emergency and EMS called to home at 11 pm 03/02/2021. Pt passed away 2 hours later at approximately 1 am 03/03/2021.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac death
Clinical narrative: Death from a cardiac event. Vaccination received 03/02/2021 in the morning before work. Cardiac emergency and EMS called to home at 11 pm 03/02/2021. Pt passed away 2 hours later at approximately 1 am 03/03/2021.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myelitis transverse
Clinical narrative: Starting one day after vaccine patient began to feel funny in her legs, that progressed to not being able to walk well. She stayed a few days in hospital and by discharge had improved but not recovered to baseline.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood thyroid stimulating hormone normal, Borrelia test negative, CSF culture negative, CSF glucose normal, CSF oligoclonal band absent
Clinical narrative: Starting one day after vaccine patient began to feel funny in her legs, that progressed to not being able to walk well. She stayed a few days in hospital and by discharge had improved but not recovered to baseline.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: CSF protein increased, Computerised tomogram spine, Feeling abnormal, Gait disturbance, Gram stain
Clinical narrative: Starting one day after vaccine patient began to feel funny in her legs, that progressed to not being able to walk well. She stayed a few days in hospital and by discharge had improved but not recovered to baseline.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gram stain negative, Lumbar puncture normal, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal normal, Vitamin B12 decreased
Clinical narrative: Starting one day after vaccine patient began to feel funny in her legs, that progressed to not being able to walk well. She stayed a few days in hospital and by discharge had improved but not recovered to baseline.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: West Nile virus test negative
Clinical narrative: Starting one day after vaccine patient began to feel funny in her legs, that progressed to not being able to walk well. She stayed a few days in hospital and by discharge had improved but not recovered to baseline.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Lethargy, Malaise, Pruritus, Rash
Clinical narrative: It started off itching and if I scratch it I'll start bleeding and my skin looks like it on fire.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash pruritic
Clinical narrative: It started off itching and if I scratch it I'll start bleeding and my skin looks like it on fire.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: It started off itching and if I scratch it I'll start bleeding and my skin looks like it on fire.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Weakness; chest pain; myalgia; very sleepy; This is a spontaneous report from a contactable consumer (patient). A 57-year-old non-pregnant female patient received bnt162b2 (Lot Number: EN6202), dose 1 via an unspecified route of administration, administered in left arm on 09Mar2021 at 14:30 (at the age of 57 years old) as 1ST single dose for covid-19 immunization. The patient had known allergies and unspecified medical history. The patient had not COVID prior vaccination and did not have COVID tested post vaccination. Concomitant medications in two weeks included unspecified drugs. The patient had no other vaccine in four weeks. The patient experienced weakness, chest pain, myalgia, and very sleepy on 09Mar2021 at 14:30. The patient underwent lab tests and procedures which included blood test with unknown results. Treatment for events included intravenous (IV) meds, crutches. The outcome of events was recovered with sequelae.   No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood test, Chest pain, Myalgia, Somnolence
Clinical narrative: Weakness; chest pain; myalgia; very sleepy; This is a spontaneous report from a contactable consumer (patient). A 57-year-old non-pregnant female patient received bnt162b2 (Lot Number: EN6202), dose 1 via an unspecified route of administration, administered in left arm on 09Mar2021 at 14:30 (at the age of 57 years old) as 1ST single dose for covid-19 immunization. The patient had known allergies and unspecified medical history. The patient had not COVID prior vaccination and did not have COVID tested post vaccination. Concomitant medications in two weeks included unspecified drugs. The patient had no other vaccine in four weeks. The patient experienced weakness, chest pain, myalgia, and very sleepy on 09Mar2021 at 14:30. The patient underwent lab tests and procedures which included blood test with unknown results. Treatment for events included intravenous (IV) meds, crutches. The outcome of events was recovered with sequelae.   No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypersensitivity, Oral mucosal eruption, Oral pain, Rash
Clinical narrative: Full body hypersensitivity rash with oral involvement starting 3 days after vaccination; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EN6200) via an unspecified route of administration administered in left arm on 06Mar2021 at 16:00 (at 55 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. There were no relevant medical history or concomitant medications. The patient had no known allergies. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. The patient experienced full body hypersensitivity rash with oral involvement starting 3 days after vaccination, which was non-serious on 09Mar2021. The patient underwent examination and received prednisone, hydroxyzine, topical steroids. Outcome of the event was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dermatitis allergic
Clinical narrative: Full body hypersensitivity rash with oral involvement starting 3 days after vaccination; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EN6200) via an unspecified route of administration administered in left arm on 06Mar2021 at 16:00 (at 55 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. There were no relevant medical history or concomitant medications. The patient had no known allergies. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. The patient experienced full body hypersensitivity rash with oral involvement starting 3 days after vaccination, which was non-serious on 09Mar2021. The patient underwent examination and received prednisone, hydroxyzine, topical steroids. Outcome of the event was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chills, Discomfort, Dizziness, Electrocardiogram normal
Clinical narrative: Chest Pain.; This is a spontaneous report from a contactable other health care professional. A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN6207, Expiration Date: not reported), intramuscularly, administered in left arm on 13Mar2021 at 14:45 (at the age of 52 years old) as first dose, single for COVID-19 immunisation. The facility where the vaccine was administered was reported to be "other". The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination and it was unknown if the patient received any other vaccines in 4 weeks. Prior to vaccine the patient was not diagnosed with COVID-19. The patient experienced chest pain on 13Mar2021 at 14:45. Treatment of the event included ALS Evaluation (as reported), and event resulted to transport to ED (emergency department). Since vaccination, it was unknown if the patient has been tested for COVID-19. Outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Heart rate increased, Laboratory test, X-ray
Clinical narrative: Chest Pain.; This is a spontaneous report from a contactable other health care professional. A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN6207, Expiration Date: not reported), intramuscularly, administered in left arm on 13Mar2021 at 14:45 (at the age of 52 years old) as first dose, single for COVID-19 immunisation. The facility where the vaccine was administered was reported to be "other". The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination and it was unknown if the patient received any other vaccines in 4 weeks. Prior to vaccine the patient was not diagnosed with COVID-19. The patient experienced chest pain on 13Mar2021 at 14:45. Treatment of the event included ALS Evaluation (as reported), and event resulted to transport to ED (emergency department). Since vaccination, it was unknown if the patient has been tested for COVID-19. Outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain
Clinical narrative: Chest Pain.; This is a spontaneous report from a contactable other health care professional. A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN6207, Expiration Date: not reported), intramuscularly, administered in left arm on 13Mar2021 at 14:45 (at the age of 52 years old) as first dose, single for COVID-19 immunisation. The facility where the vaccine was administered was reported to be "other". The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination and it was unknown if the patient received any other vaccines in 4 weeks. Prior to vaccine the patient was not diagnosed with COVID-19. The patient experienced chest pain on 13Mar2021 at 14:45. Treatment of the event included ALS Evaluation (as reported), and event resulted to transport to ED (emergency department). Since vaccination, it was unknown if the patient has been tested for COVID-19. Outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Biopsy skin, Fatigue, Pyrexia, Rash
Clinical narrative: General feeling of not being well; Severe rash/Rash over most of body but most prevalent on hands, legs and buttock.; Superfical perivascular dermatitis; Fever; Tiredness; This is a spontaneous report from a contactable consumer, the patient. An 85-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UL9269) via an unspecified route of administration in the left arm on 12Feb2021 at 11:00 (at the age of 85-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included lisinopril [UNKNOWN MANUFACTURER], metoprolol [UNKNOWN MANUFACTURER], amlodipine besylate [UNKNOWN MANUFACTURER]. Patient previously took Sulfur and experienced allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced severe rash, superficial perivascular dermatitis, fever, feeling unwell on 25Feb2021. The lab test and procedures included biopsy with result superficial perivascular dermatitis and body temperature with result fever. Therapeutic measures were taken as a result of events and resulted in visit to health care professional's clinic and included treatment with oral prednisone, cortisone cream. The clinical outcome of the severe rash, superficial perivascular dermatitis, fever, feeling unwell was resolving. No follow up attempts are possible. No further information is expected
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Biopsy, Body temperature, Fatigue, Malaise, Perivascular dermatitis
Clinical narrative: General feeling of not being well; Severe rash/Rash over most of body but most prevalent on hands, legs and buttock.; Superfical perivascular dermatitis; Fever; Tiredness; This is a spontaneous report from a contactable consumer, the patient. An 85-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UL9269) via an unspecified route of administration in the left arm on 12Feb2021 at 11:00 (at the age of 85-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included lisinopril [UNKNOWN MANUFACTURER], metoprolol [UNKNOWN MANUFACTURER], amlodipine besylate [UNKNOWN MANUFACTURER]. Patient previously took Sulfur and experienced allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced severe rash, superficial perivascular dermatitis, fever, feeling unwell on 25Feb2021. The lab test and procedures included biopsy with result superficial perivascular dermatitis and body temperature with result fever. Therapeutic measures were taken as a result of events and resulted in visit to health care professional's clinic and included treatment with oral prednisone, cortisone cream. The clinical outcome of the severe rash, superficial perivascular dermatitis, fever, feeling unwell was resolving. No follow up attempts are possible. No further information is expected
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: General feeling of not being well; Severe rash/Rash over most of body but most prevalent on hands, legs and buttock.; Superfical perivascular dermatitis; Fever; Tiredness; This is a spontaneous report from a contactable consumer, the patient. An 85-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UL9269) via an unspecified route of administration in the left arm on 12Feb2021 at 11:00 (at the age of 85-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included lisinopril [UNKNOWN MANUFACTURER], metoprolol [UNKNOWN MANUFACTURER], amlodipine besylate [UNKNOWN MANUFACTURER]. Patient previously took Sulfur and experienced allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced severe rash, superficial perivascular dermatitis, fever, feeling unwell on 25Feb2021. The lab test and procedures included biopsy with result superficial perivascular dermatitis and body temperature with result fever. Therapeutic measures were taken as a result of events and resulted in visit to health care professional's clinic and included treatment with oral prednisone, cortisone cream. The clinical outcome of the severe rash, superficial perivascular dermatitis, fever, feeling unwell was resolving. No follow up attempts are possible. No further information is expected
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anxiety, Nervousness, Palpitations, Panic attack
Clinical narrative: Severe anxiety and depression; Severe anxiety and depression; Had a very bad panic attack; Very scary; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EN6200, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 24Feb2021 14:15 (at the age of 51-years-old) as 2nd dose, single dose for COVID-19 immunisation. Medical history included scleroderma, RA (rheumatoid arthritis), hashimotos, asthma, GERD, acid reflux, gastroporesis, fibromyalgia, sulfa allergy and shellfish allergy all from an unknown date. Concomitant medications included adalimumab (HUMIRA), methotrexate, levothyroxine sodium (SYNTHROID), verapamil and cetirizine hydrochloride (ZYRTEC) all taken for an unspecified indication, start and stop date were not reported. The patient was previously vaccinated with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EL8982, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 03Feb2021 08:15 (at the age of 51-years-old)  for COVID-19 immunisation. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient has not been diagnosed with COVID-19. On 10Mar2021, the patient experienced severe anxiety and depression, had a very bad panic attack and very scary. The adverse events resulted in doctor or other healthcare professional office/clinic visit.Therapeutic measures were taken as a result of the events included counseling and medications. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was recovering.  No follow-up attempts are possible. No further information expected.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anxiety, Depression, Nervousness, Panic attack
Clinical narrative: Severe anxiety and depression; Severe anxiety and depression; Had a very bad panic attack; Very scary; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EN6200, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 24Feb2021 14:15 (at the age of 51-years-old) as 2nd dose, single dose for COVID-19 immunisation. Medical history included scleroderma, RA (rheumatoid arthritis), hashimotos, asthma, GERD, acid reflux, gastroporesis, fibromyalgia, sulfa allergy and shellfish allergy all from an unknown date. Concomitant medications included adalimumab (HUMIRA), methotrexate, levothyroxine sodium (SYNTHROID), verapamil and cetirizine hydrochloride (ZYRTEC) all taken for an unspecified indication, start and stop date were not reported. The patient was previously vaccinated with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EL8982, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 03Feb2021 08:15 (at the age of 51-years-old)  for COVID-19 immunisation. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient has not been diagnosed with COVID-19. On 10Mar2021, the patient experienced severe anxiety and depression, had a very bad panic attack and very scary. The adverse events resulted in doctor or other healthcare professional office/clinic visit.Therapeutic measures were taken as a result of the events included counseling and medications. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was recovering.  No follow-up attempts are possible. No further information expected.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bradycardia, Presyncope
Clinical narrative: Low heart rate staring 3/19 afternoon,  numerous hospitilizations and pacemaker implanted 5/14/21
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac pacemaker insertion, Heart rate decreased
Clinical narrative: Low heart rate staring 3/19 afternoon,  numerous hospitilizations and pacemaker implanted 5/14/21
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Asthenia, Breast swelling, Burning sensation, Confusional state
Clinical narrative: I felt a pain on my right side of my kidneys and they did a physical test and everything came back sick. I was in so much pain. I was running a fever and I spent 8hrs there. I had bruises all over my legs.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Laboratory test normal, Pain, Peripheral swelling, Skin discolouration
Clinical narrative: I felt a pain on my right side of my kidneys and they did a physical test and everything came back sick. I was in so much pain. I was running a fever and I spent 8hrs there. I had bruises all over my legs.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Swelling, Swelling face
Clinical narrative: I felt a pain on my right side of my kidneys and they did a physical test and everything came back sick. I was in so much pain. I was running a fever and I spent 8hrs there. I had bruises all over my legs.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Illness, Pain, Pyrexia, Renal pain
Clinical narrative: I felt a pain on my right side of my kidneys and they did a physical test and everything came back sick. I was in so much pain. I was running a fever and I spent 8hrs there. I had bruises all over my legs.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Discomfort, Feeling hot, Head discomfort, Hypoaesthesia
Clinical narrative: I felt a pain on my right side of my kidneys and they did a physical test and everything came back sick. I was in so much pain. I was running a fever and I spent 8hrs there. I had bruises all over my legs.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Limb discomfort, Paraesthesia, Peripheral swelling, Pigmentation disorder
Clinical narrative: I felt a pain on my right side of my kidneys and they did a physical test and everything came back sick. I was in so much pain. I was running a fever and I spent 8hrs there. I had bruises all over my legs.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Injection site pain, Myalgia, Pain in extremity
Clinical narrative: Injection Arm ache/pain; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: EN6207), via an unspecified route of administration on left arm on 17Mar2021 at 10.00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Patient's medical history included heart disease. The patient did not have any allergies to medications, food or any other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 18Mar2021 at 06.00, the patient experienced injection arm ache/pain after approximately 18 hours which was mild. The patient did not receive any treatment for the event. The clinical outcome of injection arm ache/pain was unknown. No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Injection Arm ache/pain; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: EN6207), via an unspecified route of administration on left arm on 17Mar2021 at 10.00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Patient's medical history included heart disease. The patient did not have any allergies to medications, food or any other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 18Mar2021 at 06.00, the patient experienced injection arm ache/pain after approximately 18 hours which was mild. The patient did not receive any treatment for the event. The clinical outcome of injection arm ache/pain was unknown. No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dizziness, Electrocardiogram, Feeling abnormal
Clinical narrative: blood pressure was high 190/114; horrible dizzy spells/ lightheadedness; when he puts his head between his shoulders he almost falls over; nauseous; sweating; This is a spontaneous report from a contactable consumer (patient).  A 67-year-old male patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 03Mar2021 (Lot number was not reported) as single dose for covid-19 immunisation.  Medical history and concomitant medications were not reported. On unknown date in Mar2021 patient experienced horrible dizzy spells, lightheadedness, when he puts his head between his shoulders he almost falls over, blood pressure was high 190/114, nauseous, sweating. Patient stated that he received the first dose of the Pfizer COVID vaccine on 03Mar2021. He did not have any problems directly after the vaccine. Patient started having problems the middle of the week of the report with horrible dizzy spells and lightheadedness. Patient stated that when he puts his head between his shoulders he almost falls over. He was taken to the emergency room by ambulance and had an Electrocardiogram (EKG) done in Mar2021 that was normal. Patient stated that his blood pressure was high 190/114 and he was given medication for it. Patient had been nauseous and sweating. Patient had read on the internet that other people have had this same experience. He stated that his symptoms are really debilitating. Patient wanted to know how long his side effects will last, wanted to know if his side effects are normal and if he should receive the second dose of the vaccine. Events resulted in emergency room visit. Outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Memory impairment, Myocardial infarction, Nausea, Ocular discomfort
Clinical narrative: blood pressure was high 190/114; horrible dizzy spells/ lightheadedness; when he puts his head between his shoulders he almost falls over; nauseous; sweating; This is a spontaneous report from a contactable consumer (patient).  A 67-year-old male patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 03Mar2021 (Lot number was not reported) as single dose for covid-19 immunisation.  Medical history and concomitant medications were not reported. On unknown date in Mar2021 patient experienced horrible dizzy spells, lightheadedness, when he puts his head between his shoulders he almost falls over, blood pressure was high 190/114, nauseous, sweating. Patient stated that he received the first dose of the Pfizer COVID vaccine on 03Mar2021. He did not have any problems directly after the vaccine. Patient started having problems the middle of the week of the report with horrible dizzy spells and lightheadedness. Patient stated that when he puts his head between his shoulders he almost falls over. He was taken to the emergency room by ambulance and had an Electrocardiogram (EKG) done in Mar2021 that was normal. Patient stated that his blood pressure was high 190/114 and he was given medication for it. Patient had been nauseous and sweating. Patient had read on the internet that other people have had this same experience. He stated that his symptoms are really debilitating. Patient wanted to know how long his side effects will last, wanted to know if his side effects are normal and if he should receive the second dose of the vaccine. Events resulted in emergency room visit. Outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Scan brain, Vertigo
Clinical narrative: blood pressure was high 190/114; horrible dizzy spells/ lightheadedness; when he puts his head between his shoulders he almost falls over; nauseous; sweating; This is a spontaneous report from a contactable consumer (patient).  A 67-year-old male patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 03Mar2021 (Lot number was not reported) as single dose for covid-19 immunisation.  Medical history and concomitant medications were not reported. On unknown date in Mar2021 patient experienced horrible dizzy spells, lightheadedness, when he puts his head between his shoulders he almost falls over, blood pressure was high 190/114, nauseous, sweating. Patient stated that he received the first dose of the Pfizer COVID vaccine on 03Mar2021. He did not have any problems directly after the vaccine. Patient started having problems the middle of the week of the report with horrible dizzy spells and lightheadedness. Patient stated that when he puts his head between his shoulders he almost falls over. He was taken to the emergency room by ambulance and had an Electrocardiogram (EKG) done in Mar2021 that was normal. Patient stated that his blood pressure was high 190/114 and he was given medication for it. Patient had been nauseous and sweating. Patient had read on the internet that other people have had this same experience. He stated that his symptoms are really debilitating. Patient wanted to know how long his side effects will last, wanted to know if his side effects are normal and if he should receive the second dose of the vaccine. Events resulted in emergency room visit. Outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Dizziness, Electrocardiogram, Feeling abnormal, Hyperhidrosis
Clinical narrative: blood pressure was high 190/114; horrible dizzy spells/ lightheadedness; when he puts his head between his shoulders he almost falls over; nauseous; sweating; This is a spontaneous report from a contactable consumer (patient).  A 67-year-old male patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 03Mar2021 (Lot number was not reported) as single dose for covid-19 immunisation.  Medical history and concomitant medications were not reported. On unknown date in Mar2021 patient experienced horrible dizzy spells, lightheadedness, when he puts his head between his shoulders he almost falls over, blood pressure was high 190/114, nauseous, sweating. Patient stated that he received the first dose of the Pfizer COVID vaccine on 03Mar2021. He did not have any problems directly after the vaccine. Patient started having problems the middle of the week of the report with horrible dizzy spells and lightheadedness. Patient stated that when he puts his head between his shoulders he almost falls over. He was taken to the emergency room by ambulance and had an Electrocardiogram (EKG) done in Mar2021 that was normal. Patient stated that his blood pressure was high 190/114 and he was given medication for it. Patient had been nauseous and sweating. Patient had read on the internet that other people have had this same experience. He stated that his symptoms are really debilitating. Patient wanted to know how long his side effects will last, wanted to know if his side effects are normal and if he should receive the second dose of the vaccine. Events resulted in emergency room visit. Outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypertension, Nausea
Clinical narrative: blood pressure was high 190/114; horrible dizzy spells/ lightheadedness; when he puts his head between his shoulders he almost falls over; nauseous; sweating; This is a spontaneous report from a contactable consumer (patient).  A 67-year-old male patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 03Mar2021 (Lot number was not reported) as single dose for covid-19 immunisation.  Medical history and concomitant medications were not reported. On unknown date in Mar2021 patient experienced horrible dizzy spells, lightheadedness, when he puts his head between his shoulders he almost falls over, blood pressure was high 190/114, nauseous, sweating. Patient stated that he received the first dose of the Pfizer COVID vaccine on 03Mar2021. He did not have any problems directly after the vaccine. Patient started having problems the middle of the week of the report with horrible dizzy spells and lightheadedness. Patient stated that when he puts his head between his shoulders he almost falls over. He was taken to the emergency room by ambulance and had an Electrocardiogram (EKG) done in Mar2021 that was normal. Patient stated that his blood pressure was high 190/114 and he was given medication for it. Patient had been nauseous and sweating. Patient had read on the internet that other people have had this same experience. He stated that his symptoms are really debilitating. Patient wanted to know how long his side effects will last, wanted to know if his side effects are normal and if he should receive the second dose of the vaccine. Events resulted in emergency room visit. Outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Influenza like illness, Pain in extremity
Clinical narrative: Two days after vaccine, flue like symptoms. Third morning couldn't hear out of left ear. Few days it cleared up but now has ringing in left ear and worse ringing in the right ear. Now gets a rash when skin is exposed to the sun. Still very fatigued since the vaccine and has been sleeping 10 to 12 hours a night.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deafness unilateral, Fatigue, Influenza like illness, Photosensitivity reaction, Somnolence
Clinical narrative: Two days after vaccine, flue like symptoms. Third morning couldn't hear out of left ear. Few days it cleared up but now has ringing in left ear and worse ringing in the right ear. Now gets a rash when skin is exposed to the sun. Still very fatigued since the vaccine and has been sleeping 10 to 12 hours a night.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Two days after vaccine, flue like symptoms. Third morning couldn't hear out of left ear. Few days it cleared up but now has ringing in left ear and worse ringing in the right ear. Now gets a rash when skin is exposed to the sun. Still very fatigued since the vaccine and has been sleeping 10 to 12 hours a night.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blister, Ear discomfort, Feeling abnormal, Oropharyngeal pain, Sensory disturbance
Clinical narrative: shingles; blisters; hives; very sore, burning throat; was swollen on one side; very sore, burning throat; was swollen on one side; very sore, burning throat; was swollen on one side; This is a spontaneous report from a contactable consumer or other non hcp(patient).    patient received BNT162B2 (BNT162B2, PFIZZER-BIOECH COVID-19 VACCINE, Batch/Lot Number: EN6199), via an unspecified route of administration on 07Mar2021 as first dose, single for covid-19 immunization. Medical history included shingles from 2005 to an unknown date, hypothyroidism from 2010 to an unknown date. The patients concomitant medications were not reported. Prior Vaccinations (within 4 weeks): None. It was reported that patient received the first dose of the covid vaccine on 07Mar2021.Seven days after, she had a very sore, burning throat, and it was swollen on one side. She developed hives. Then she had shingles blisters two weeks later. Her primary care physician recommended her not to have the second dose of the Pfizer covid vaccine. She developed hives: Began on 16Mar2021. The shingle blisters started right after the hives went away. The shingles blisters lasted for about two weeks. Outcome for the events shingles, blisters was resolved on Apr2021, and for remaining events outcome was resolved on 18Mar2021.     No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: shingles; blisters; hives; very sore, burning throat; was swollen on one side; very sore, burning throat; was swollen on one side; very sore, burning throat; was swollen on one side; This is a spontaneous report from a contactable consumer or other non hcp(patient).    patient received BNT162B2 (BNT162B2, PFIZZER-BIOECH COVID-19 VACCINE, Batch/Lot Number: EN6199), via an unspecified route of administration on 07Mar2021 as first dose, single for covid-19 immunization. Medical history included shingles from 2005 to an unknown date, hypothyroidism from 2010 to an unknown date. The patients concomitant medications were not reported. Prior Vaccinations (within 4 weeks): None. It was reported that patient received the first dose of the covid vaccine on 07Mar2021.Seven days after, she had a very sore, burning throat, and it was swollen on one side. She developed hives. Then she had shingles blisters two weeks later. Her primary care physician recommended her not to have the second dose of the Pfizer covid vaccine. She developed hives: Began on 16Mar2021. The shingle blisters started right after the hives went away. The shingles blisters lasted for about two weeks. Outcome for the events shingles, blisters was resolved on Apr2021, and for remaining events outcome was resolved on 18Mar2021.     No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blister, Herpes zoster, Oropharyngeal pain, Swelling, Throat irritation
Clinical narrative: shingles; blisters; hives; very sore, burning throat; was swollen on one side; very sore, burning throat; was swollen on one side; very sore, burning throat; was swollen on one side; This is a spontaneous report from a contactable consumer or other non hcp(patient).    patient received BNT162B2 (BNT162B2, PFIZZER-BIOECH COVID-19 VACCINE, Batch/Lot Number: EN6199), via an unspecified route of administration on 07Mar2021 as first dose, single for covid-19 immunization. Medical history included shingles from 2005 to an unknown date, hypothyroidism from 2010 to an unknown date. The patients concomitant medications were not reported. Prior Vaccinations (within 4 weeks): None. It was reported that patient received the first dose of the covid vaccine on 07Mar2021.Seven days after, she had a very sore, burning throat, and it was swollen on one side. She developed hives. Then she had shingles blisters two weeks later. Her primary care physician recommended her not to have the second dose of the Pfizer covid vaccine. She developed hives: Began on 16Mar2021. The shingle blisters started right after the hives went away. The shingles blisters lasted for about two weeks. Outcome for the events shingles, blisters was resolved on Apr2021, and for remaining events outcome was resolved on 18Mar2021.     No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Chills, Death, Pain, Pyrexia
Clinical narrative: Patient presented to local hospital on 3/21/21 after feeling unwell, vomiting, and having garbled speech as per her son. She was noted to have left hemiparesis. Her airway was obstructed with emesis and she was emergently  intubated. CT head did not show intracranial hemorrhage or acute mass effect. However, CT angiogram of the head and neck reported : "1. There is fresh-appearing thrombus within the cervical segment of the RIGHT internal carotid artery. The origin of the cervical segment of the right internal carotid artery opacifies normally. It is subsequently narrowed by thrombus, and becomes completely occluded by thrombus approximately 1.5 cm distal to the bifurcation. There is no reconstitution within the neck.   2. The petrous, precavernous, cavernous, and proximal supraclinoid segments of the RIGHT internal carotid artery are occluded. There is reconstitution within the supraclinoid segment of the right internal carotid artery just proximal to the carotid terminus at the level of the origin of the hypoplastic right posterior communicating artery.    3. The proximal intraorbital portion of the RIGHT ophthalmic artery opacifies, however the origin and portion within the optic canal are not visualized.    4. There is diminished opacification and caliber of the RIGHT internal cerebral vein compared to the left side, possibly secondary to ipsilateral cerebral oligemia."  She also was noted to have a first cardiac troponin of 1.5, and EKG reported an anteroseptal infarct, "possibly acute."  She was flown by helicopter Hospital the same night. Platelets count on admission to hospital was 19 and rechecked at hospital at 25. She was given one unit of platelets, and then she was sent to the cardiac cath lab where there was an ostial occlusion of the LAD with thrombus. The cath lab team was unable to aspirate the thrombus due to its size. They placed an LAD stent as well as an intra-aortic balloon pump and sent her back to the ICU. Repeat CBC post-cash lab showed platelet increase to 43, but by the next morning (3/22) platelets went down to 23. On 3/22, she remained hypotensive requiring pressors, developed acute kidney injury, COVID PCR was negative, neuro exam still showed left hemiparesis, and no response to tactile stimuli. Later in the evening, she was noted to have a fixed and dilated R pupil. Patient had another CT head done (non contrast) that reported a large acute infarct in the right ACA territory, with associated swelling and compression of the right lateral ventricle, as well as midline shift to the left of approximately 10 mm.  Patient's husband declined heroic neurosurgical intervention, and she was pronounced dead on 3/23/21 at 0028.